Legato Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
2025
Q4
$1.27M Buy
2025
Q3
$396K Sell
2025
Q2
$1.82M Buy
2025
Q1
$1.22M Buy
2024
Q4
$226K Sell
2024
Q3
$353K Buy